Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care.
第一作者:
Sarah L,Alderson
第一单位:
School of Medicine, Leeds Institute of Health Sciences, University of Leeds, University of Leeds, Room 10.39, Worsley Building, Clarendon Way, Leeds, LS9 9LU, UK. s.l.alderson@leeds.ac.uk.
作者:
医学主题词
成年人(Adult);阿米替林(Amitriptyline);双盲法(Double-Blind Method);人类(Humans);肠易激综合征(Irritable Bowel Syndrome);多中心研究(主题)(Multicenter Studies as Topic);初级卫生保健(Primary Health Care);生活质量(Quality of Life);随机对照试验(主题)(Randomized Controlled Trials as Topic);治疗结果(Treatment Outcome)
DOI
10.1186/s13063-022-06492-6
PMID
35804433
发布时间
2022-07-16
- 浏览1
Trials
552页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



